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In the Captopril And Thrombolysis Study, 298 patients (age: 59 ± 10) with
first anterior myocardial infarction treated with IV streptokinase were ran-
domized to either oral captopril or placebo. Left ventricular end-diastolic
and end-systolic volume index (LVEDVI and LVESVI) were assessed by 2D
echocardiography within 24 hours, at day 3 and 10, after three months and
after one year. Ninety-nine patients underwent CR by PTCA (n = 76) or CABG
(n = 23) on clinical indication at 34 days (range 1 to 293) after onset of symp-
toms. Baseline characteristics of CR patients were comparable to those of
patients not receiving active revascularization (NCR). During the follow-up
NCR patients, as contrasted to CR-patients, showed a gradual increase in
LVEDVI of 9 ml/mZ (95%CI; 5-13). Dilatation (defined as LVEDVI >64 and/or
LVESVI >29 ml/m2 ) occurred more frequently in the NCR-group (47% vs
29%, P = 0.0004).
Conclusion: Coronary revascularization in addition to thrombolytic therapy
may further reduce the risk for ventricular dilatation during the first year after
myocardial infarction
Cardiomyopathy - Dilated and Hypertrophic
normal LVEDP high LVEDP
ICM DCM (CM DCM
n 21 17 27 25
LVEDP (mmHg) 8.7 ± 3.2 ns 8Z ± 3.5 226 ± 5.1 ns 19.8 ± 7.2
LV % fraction shortening 20 ± 5 ns 18 ± 7 16 ± 5 ns 16±6
Ecorrected by age (%) 101 ± 41 ns 96 ± 34 106±53ns 94 ± 40
A corrected by age (%) 112 ± 45 ns 111 ±51 103±47' 70 ± 36
AlE corrected by age (%) 124 ± 46 ns 106 ± 58 102 ± 45' 67 ± 49
Atrial filling fraction (%) 39±13ns 35 ± 11 33 ± 13' 21 ± 12
LV + dp/dt in atrial systole 137±B9ns 128 ± 73 260 ± 92' Z17 ± 94
'p < 0.05, significant difference between ICM and DCM by ANOVA
Only in high LVEOP groups, reverse pulmonary venous flow velocity in
atrial systole measured by transesophageal echo was higher in ICM than
in DCM (20 ± 4 vs 15 ± 4 cm/s). Autopsy showed severely fibrotic LA my-
ocardium in 1 patient with OCM but not in 4 with ICM. Thus, LA booster
pump function is not enough to fill LV in atrial systole in severe DCM with
high LVEDP presumably because of involvement of LA with cardiomyopathic
process.
Hirofumi Kanda, Hitoshi Ishihara, Kohzo Nagata, Ryozo Kato, Toshikazu Sobue,
Mitsuhiro Yokota 1. First Department of Internal Medicine, Nagoya University School of
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OPC-18790 is a novel inotropic agent which works partially by inhibiting
phosphodiesterase without a positive chronotropic effect. The purpose of
this study was to examine the effects of OPC-1 8790 on mechanoenergetics
in patients with idiopathic dilated cardiomyopathy (DCM) in comparison with
the effects of dobutamine. Twenty patients with DCM (LVEF < 50%) received
either OPC-18790 infusion (5-10 JLglkg/min, n = 10), or dobutamine (2.5-5
JLg/kg/min, n = 10). Measurements of heart rate (HR), left ventricular end-
diastolic volume index (LVEDVll. left ventricular end-systolic elastance (Ees),
effective arterial elastance lEa), myocardial oxygen consumption (MVOz), ex-
ternal work (EWl. and pressure-volume area (PVA) were obtained by using
conductance catheter and Webster catheter before and after administration
of each drug. 0.87'0.62
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Antiarrhythmic Effect of Long-term /:I-Blocker
Therapy for Dilated Cardiomyopathy on Survival
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Hiroshi Oe, Masatake Fukunami, Masaharu Ohmori, Kazuaki Kumagai,
Takahisa Yamada, Yasushi Abe, Nagahiro Nishikawa. Jiyoong Kim, Motoo Date,
Noritake Hoki. Division of Cardiology, Osaka Prefectural Hospital, Osaka, Japan
To clarify how the long-term tl-blocker (I'll therapy for the patients (pts) with
dilated cardiomyopathy (DCM) improves the rate of freedom from cardiac
death (RFCDj, 57 DCM pts with tl (metoprolol; 40-60 mg/day) (G-l, follow-
up; 6-120 M) and 72 DCM pts without tl (G-2, follow-up; 6-102 M) were
followed up. The survival was confirmed by annual interview. The cause of
death and the preterminal condition of the pts were obtained from family
members, medical personnel or medical recordings. The RFCO was analyzed
with Kaplan-Meier life table method. At entry, there were no significant dif-
ferences in age, sex, blood pressure, heart rate, left ventricular end-diastolic
dimension (64.0 ± 6.0 vs 63.5 ± 6.8 mm) and ejection fraction (40.7 ± 9.1
vs 42.3 ± 8.3%) measured by echocardiography, and the severity of ven-
tricular arrhythmia by 24 hours Holter monitoring (according to the Lawn's
grade) between G-l and G-2. During the follow-up period, non-cardiac death
occurred in 2 pts in G-1 and in 3 pts in G-2. The annual RFCD were calculated
as shown below;
G-l
G-2
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Beneficial Effects of OPC-18790 on
Mechanoenergetlcs in Patients with Idiopathic
Dilated Cardiomyopathy
1941-161
mean value ± SEM. 'p < 0.05, "p < 0.01. '''p < 0.001 vs before
OPC-l 8790 decreased MV02 and improved mechanical efficiency partially
due to an adequate balance between inotropic and preload reducing effect.
OPC-18790 may be useful for treating patients with congestive heart failure.
OPC-18790 Dobutamine
before after before after
HR{min-1) 79 ± 4 85 ± 6 79 ± 5 97 ± 5***
LVEDVI(mUm2j 126 ± 11 109 ± 7*' 150 ± 7 141 ± 11
Ees(mmH9/mL) 1.73 ± 0.31 2.48 ± 0.48' 0.72 ± 009 1.42 ± 0.18'"
EalmmHg/mL) 217 ± 0.27 1.79 ± 0.22 2.16±022 2.44 ± 044
MV02lJlbeat) 4.51 ± 0.66 3.61 ± 0.62' 516±074 7.27 ± 1.30**
EW{J/beatl 0.70 ± 0.06 0.65 ± 010 0.90 ± 011 1.09 ± 0.13**
EW/PVA(%) 41.4±3.4 59.6 ± 5.1" 30.3 ± 29 47.0 ± 5.0'"
EW/MV02(%) 17.4±2.3 21.0 ± 3.0' 203 ± 3.0 17.9 ± 2.6'
Yuepeng Wang, Katsu Takenaka, Yukihiro Kuwada, Makoto Sonoda.
Tsutomu Igarashi, Fumiyoshi Watanabe, Masao Omata. University of Tokyo, Tokyo,
Japan
Ischemic process rarely involves the LA. To test the hypothesis that LA
booster pump function is impaired in idiopathic dilated cardiomyopathy
(DCM) but not in ischemic cardiomyopathy (ICM), peak Doppler mitral flow
velocities in early diastole (E) and in atrial systole (Al. and other indexes were
measured within 24 hours of cardiac catheterization in 48 patients with ICM
and 42 with OCM. Patients were divided into subgroups with normal «12
mmHg) and high (;:: 12 mmHg) LV end-diastolic pressure ILVEOP).
A Scintigraphic Prognostication is Important in
Young Patients with Idiopathic Dilated
Cardiomyopathy
'p < 0.05. # P < 0.01 vs G-2
The number of death from heart failure did not show significant difference
between G-1 (3 of 57 pts) and G-2 (4 of 72 pts). On the other hand, sudden
death has occurred more often in G-2 (1 0 of 72 pts) than in G-1 (1 of 57 pts) (p
< 0.05), resulting in that the RFCD was significantly better in G-l than in G-2.
These results indicate that the long-term tl-blocker therapy for OCM might
improve the rate of freedom from cardiac death due to prevention of sudden
death rather than of death from heart failure.
Takashi Furuno, Jun Takata, Toshikazu Yabe. Yoshihisa Matsumura,
Taishiro Chikamori, Syoji Yoshida, Yoshinori Doi. Kochi Medical School, Kochi, Japan
Identification of candidates for early cardiac transplantation and of those who
can wait is important, partiCUlarly in patients (pts) with idiopathic dilated car-
diomyopathy (DCM). To evaluate the significance of thallium-201 perfusion
defect (PD) and age in prognostication, 70 DCM pts underwent thallium scan
as well as clinical and hemodynamic examination. Results; (1) An abnormal
PD was present in 22 of 36 young pts (61 %) aged <60 years and in 25 of 34
elderly pts (74%) aged ;0:60 years (ns). (2) In the uni-variate analysis, PO was
a significant predictor of cardiac death only in young OCM pts (p = 0.0031).
Stepwise discriminant analysis also revealed that PO was again a significant
predictor in young pts (Wilks lambda 0.4958, chi-square 14.733, p = 0.0224),
although it was not more important than the history of synco'pe or stroke in
elderly DCM pts. (3) During 55 ± 41 months, 20 pts had disease-related mor-
tality. In young OCM pts, 5 years survival rate was better in pts without than
in those with PO 11.0 vs 0.56, respectively), although it was not affected by
PO in the elderly (0.67 vs 0.66).
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Left Atrial Booster Pump Function In Patients with
Ischemic Cardiomyopathy and Idiopathic Dilated
Cardiomyopathy
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Francesco Pelliccia, Cinzia Cianfrocca, Stefano De Castro, Francesco Pizzuto,
Giuseppe Critelli. Department of Cardiology. University "La Sapienza~ Rome, Italy
Measurements of LV morphology and function at rest predict weakly exer-
cise capacity in hypertrophic cardiomyopathy (HC). Aim of this study was to
verify whether dynamic changes in LV function relate to exercise duration
in He. Accordingly, we studied 25 patients, off-drugs, with nonobstructive
HC (15 males, aged 43 ± 13 yrs). who undervvent baseline Doppler echocar-
diography, cardiac catheterization, and symptom-limited supine bicycle ex-
ercise (25 watt/2 mins) with postexercise Doppler echocardiography. Exer-
cise capacity ranged from 50 to 125 (mean: 79 ± 27) watts. No relation was
found between exercise time and indices of LV morphology(i.e. maximal wall
thickness, wall thickness index, end-diastolic and end-systolic dimensions).
or function at rest Ii.e. LV ejection fraction. stroke volume index, right- and
left-sided intracavitary pressures, Doppler indices of LV diastolic filling). In
contrast, exercise capacity correlated significantly (p < 0.01) with the mag-
nitude of changes recorded at peak exercise in ejection fraction (r = 0.65).
LV end-diastolic volume (r = 0.67), and Doppler peak early filling velocity (r
= 0.60). Change in ejection fraction related significantly (p < 0.01) to change
from baseline in both LV end-diastolic volume (r = 0.71) and peak early filling
velocity(r = 0.55). Multiple regression analysis revealed that the response of
ejection fraction to exercise was the strongest predictor of exercise capacity
(p = 0.001). Noteworthy. 10/25 patients exhibited the lack of stress-induced
increase in ejection fraction. We conclude that in nonobstructive HC: (1) dy-
namic changes in LV function correlate with exercise duration; (2) indices of
LV morphology and function at rest do not predict exercise capacity; (3) exer-
cise intolerance seems to be caused by worsening in diastolic filling, leading
to the inability to increase LV volume with exercise to maintain systolic func-
tion.
ing that exercise-induced ischemia of the hypertrophied myocardium may
playa role.
Role of Dynamic Changes in Left Ventricular
Function in Determining Exercise Capacity in
Patients with Nonobstructive Hypertrophic
Cardiomyopathy
Congenital and Acquired Valvular Heart
Disease
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Carcinoid Heart Disease: Correlation of High
Serotonin Levels with Valvular Abnormalities
Detected by Cardiac Catheterization and
Echocardiography
Paul A. Robiolio, Vera H. Rigolin, John S. Wilson, J. Kevin Harrison, Jerome
M. Feldman, Thomas M. Bashore. Duke University Medical Center, Durham, NC
Background: Although seratonin has been postulated as an etiologic agent
in the development of carcinoid heart disease, no direct evidence for differ-
ent ambient serotonin levels in cardiac and noncardiac patients has been
reported to date.
Methods and Results: The present study reviews the experience with 604
patients in the Duke Carcinoid Database. Nineteen patients with proven
carcinoid heart disease (by cardiac catheterization andlor echocardiogra-
phy) were compared with the remaining 585 noncardiac patients in the
database with regard to circulating serotonin and its principle metabolite.
5-hydroxyindoleacetic acid (5-HIM). No significant demographic differences
existed between the cardiac and noncardiac groups; however, typical car-
cinoid syndrome symptoms (i.e. flushing and diarrhea) were almost three-
fold more common in the cardiac group (p < 0.001). The spectrum of heart
disease among the 19 patients showed a strong right-sided valvular pre-
dominance with tricuspid regurgitation being the most common valvular
dysfunction 192% by cardiac catheterization; 100% byechocardiography).
No survival differences were found between the cardiac and noncardiac
groups. Compared with the noncardiac group. heart disease patients demon-
strated strikingly higher (p < 0.0001) mean serum serotonin (9750 vs 4350
pmoles/ml). plasma serotonin (1130 vs 426 pmoles/ml), platelet serotonin
(6240 vs 2700 pmoleslmg protein). and urine 5-HIAA (219 vs 55.3 mg/24 hr).
Conclusions: These data suggest that serotonin plays a major role in the
pathogenesis of the cardiac plaque formation observed in carcinoid patients.
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Safety of Cardiac Biopsy Based on the 32-year
Experience in Japan
Shinya Hiramitsu, Michiaki Hiroe, Shin-ichiro MOrimoto, KenJi Yamada,
Akihisa Uemura, Natsuko Kubo, Katsutomo Kimura, Fumiaki Marumo,
Yoshihiko Watanabe, Hitoshi Hishida. Department of Internal Medicine, Fujita Health
University. Toyoake, Aichi, Japan; 2nd Department of Internal Medicine, Tokyo Medical
and Dental University. Tokyo, Japan
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Exercise-induced Global and Regional Diastolic
Dysfunction in Hypertrophic Cardiomyopathy
Kohzo Nagata, Hitoshi Ishihara, Toshikazu Sobue, Mitsuhiro Yokota. Clinical
Laboratory Medicine, Nagoya University School of Medicine, Nagoya, Japan
In order to estimate the safety of cardiac biopsy, questionnaires were sent
to 852 Japanese institutions, where cardiac specialists work.
Results; We received replies from 214 institutions (25%). which were con-
sidered to include almost all major institutions performing cardiac biopsy in
Japan. Cardiac biopsy was carried out in 134 institutions 163%). 5.5 times
more than in Sekiguchi's survey in 1980. A total of 19,964 biopsies were per-
formed in Japan from 1960 to 1992, 2,452 in one recent year. Diseases sub-
mitted included dilated cardiomyopathy (27.3%), hypertrophic cardiomyopa-
thy (29.6%), constrictive cardiomyopathy (0.6%), myocarditis (13.0%), other
specific heart muscle diseases (11.8%) and the others (17.7%). One hundred
thirteen institutions took specimens from the right ventricle and 76 institu-
tions from the left ventricle. The Konno-Sakakibara bioptome was used in
only 32 institutions and the long sheath method in the others. The average
number of specimens was 2.8 from right ventricle and 2.2 from left ventricle.
Ventricular perforation occurred in 146 (115: right ventricle, 31 : left ventricle)
of the 19,964 cases (0.7%). No other major complication was reported. The
mortality during the procedure was 0.05% (10/19,964 cases). Six of the 115
cases (5.2%) of right ventricular perforation and 4 of the 31 cases (12.9%) of
left ventricular perforation died. The mortality was significantly higher in the
case of left ventricular perforation (p < 0.05).
Conclusion: Based on the experience in Japan for 32 years, the mortal-
ity associated with cardiac biopsy was 0.05%, which was the same as for
coronary angiography and considered sufficiency low.
Conclusion; Scintigraphic prognostication is important in DCM patients
aged <60 years who could usually be candidates for cardiac transplantation.
Absence of thallium perfusion defects may indicate good long-term progno-
sis.
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Hypertrophic cardiomyopathy (HCM) is known to cause diastolic dysfunc-
tion. However, little studies have evaluated alterations in global and regional
diastolic function during exercise in this disease. We studied 9 patients with
HCM with asymmetric septal hypertrophy and normal systolic function with
simultaneous recordings of micromanometer left ventricular (LV) pressure
and M-mode echocardiogram. All patients had normal epicardial coronary
arteries. The modulus of chamber stiffness was obtained by curve-fitting the
diastolic pressure-volume (Teichholtz) data in exponential form. The modu-
lus of regional myocardial stiffness was obtained by curve-fitting the rela-
tion between the mean wall stress and the natural logarithm of reciprocal of
wall thickness of interventricular septum and the posterior wall in diastole
in exponential form. Data were obtained at rest and during supine bicycle
exercise (25 watts). LV end-diastolic pressure increased from 19 ± 6 to 33
± 6 mmHg (p < 0.01), but LV end-diastolic dimension was unchanged. LV
minimum pressure increased from 10 ± 3 to 18 ± 6 mmHg (p < 0.05), and
the time constant of isovolumic relaxation (Raff and Glantz) increased from
72 ± 14 to 82 ± 7 msec (p < 0.05). The left ventricular diastolic pressure-
dimension (volume) relation shifted upward in all patients. The modulus of
chamber stiffness increased from 0.7 ± 0.4 to 1.9 ± 1.3 (p < 0.05). The mod-
ulus of regional myocardial stiffness at rest was greater in interventricular
septum than that of the posterior wall (7.7 ± 4.2 vs. 5.2 ± 1.9, P < 0.05).
The regional myocardial stiffness constant increased significantly during ex-
ercise in interventricular septum (p < 0.05), whereas it was not significantly
changed in the posterior wall.
In conclusion, both impaired relaxation and increased chamber stiffness
are responsible for exercise-induced diastolic dysfunction in HCM, suggest-
